Pages that link to "Q38926034"

The following pages link to Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma (Q38926034):

Displaying 26 items.

• New perspectives in glioblastoma antiangiogenic therapy (Q26746028) (← links)
• Pre-Clinical Models of Diffuse Intrinsic Pontine Glioma (Q26799976) (← links)
• The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. (Q34043405) (← links)
• ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B-Driven Brainstem Glioma Model (Q36918220) (← links)
• Genomic Insights into Diffuse Intrinsic Pontine Glioma. (Q37723508) (← links)
• Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases (Q38639065) (← links)
• Recurrent MET fusion genes represent a drug target in pediatric glioblastoma (Q38735138) (← links)
• Patient-derived Tumor Models for Diffuse Intrinsic Pontine Gliomas (Q38841339) (← links)
• Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma (Q41109977) (← links)
• Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors (Q47158930) (← links)
• Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope? (Q47580461) (← links)
• Culture methods of diffuse intrinsic pontine glioma cells determine response to targeted therapies (Q47745284) (← links)
• Rapid and fulminant leptomeningeal spread following radiotherapy in diffuse intrinsic pontine glioma (Q48358844) (← links)
• Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma. (Q52684145) (← links)
• NEM157 (Q54930394) (← links)
• NEM163 (Q54930396) (← links)
• NEM165 (Q54930397) (← links)
• NEM168 (Q54930398) (← links)
• CDK4/6 and PDGFRA Signaling as Therapeutic Targets in Diffuse Intrinsic Pontine Glioma. (Q55351090) (← links)
• Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma. (Q55456561) (← links)
• International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma (Q63722737) (← links)
• Invaders Exposed: Understanding and Targeting Tumor Cell Invasion in Diffuse Intrinsic Pontine Glioma (Q89967058) (← links)
• Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma (Q90453051) (← links)
• A kinome-wide shRNA screen uncovers vaccinia-related kinase 3 (VRK3) as an essential gene for diffuse intrinsic pontine glioma survival (Q92035715) (← links)
• Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/GSK-3β/NF-κB signaling pathway (Q92642734) (← links)
• CAR T Cell Therapy for Pediatric Brain Tumors (Q99237709) (← links)